Harnessing the Gut Microbiota to Potentiate the Efficacy of CAR T Cell Therapy
Giulia Gabrielli(University of Turin), Marco Ruella(Parker Institute for Cancer Immunotherapy), Marcel R.M. van den Brink(City Of Hope National Medical Center), Roni Shouval(Memorial Sloan Kettering Cancer Center), Guido Ghilardi(Hospital of the University of Pennsylvania)
Cited by 8
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
|Blood|2014|880
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
|Journal of Clinical Investigation|2016|554